COVID19 Clinical Trials in Fayetteville, NC
A listing of COVID19 Clinical Trials in Fayetteville, NC actively recruiting patient volunteers.
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Search
Filter by Condition
COVID19
Filter by Age
Filter by Type
Gender
Type of Study
Clinical Trial Phase
Search by Name
Search
Filter by Condition
COVID19
1 trials found
Featured Trial
Recruiting
A Vaccine Trial For Healthy Women Between 16-40
A Cytomegalovirus (CMV) Investigational Vaccine Clinical Trial for Healthy Women Age 16 to 40. Compensation included.
Conditions:
Healthy Volunteers
Healthy
* Compensation for time may be available
Featured Trial
Recruiting
Paid Clinical Studies Nationwide
Nationwide clinical trials offering up to $3,000 for participation and treatment.
Conditions:
Healthy
* Compensation for time may be available
Featured Trial
Recruiting
CMV Vaccine Trial For Men
A vaccine clinical study to evaluate an investigational vaccine.
Conditions:
Healthy
* Compensation for time may be available
Featured Trial
Recruiting
PTSD Clinical Study
The Monarch study is being conducted in study sites across the U.S. and will enroll 270 adults aged 18 to 70 who have been diagnosed with PTSD.
Conditions:
Healthy
PTSD
Posttraumatic Stress Disorder (PTSD)
Post-traumatic Stress Disorder (PTSD)
Post Traumatic Stress Disorder (PTSD)
PTSD
Post Traumatic Stress Disorder
PTSD Symptoms
Family PTSD
Post Traumatic Stress Disorder
Stress Disorders
Post Traumatic
Stress
Posttraumatic Stress Disorder
Post-Traumatic Stress Disorder
Stress
Psychological
Stress Disorders
Post-Traumatic
Anxiety
Anxiety Disorders
Generalized Anxiety Disorder
Anxiety Disorder
* Compensation for time may be available
Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) Patients
NCT04603924
Study of ANA001 in Moderate and Severe COVID-19 Patients
Conditions: COVID-19
Phase: Phase 2/3
